ACTINIUM PHARMACEUTICALS, INC.: 10-Q filed 2012-11-14

Name: ACTINIUM PHARMACEUTICALS, INC.: 10-Q filed 2012-11-14
Creator: ACTINIUM PHARMACEUTICALS, INC.

What ACTINIUM PHARMACEUTICALS, INC. reported in its quarterly report filed 2012-11-14 (fiscal Q3 2012): 26 published measures, 59 facts as tagged in accession 0001078782-12-002804.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-11-14
Fiscal period: fiscal Q3 2012
Accession: 0001078782-12-002804 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ACTINIUM PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-09-30	0	USD
At 2011-12-31	150	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-09-30	103,993	USD
At 2011-12-31	84,479	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-09-30	-103,993	USD
At 2011-12-31	-84,329	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-09-30	0	USD
At 2011-09-30	150	USD
At 2010-09-30	150	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-3,717	USD	92
2012-01-01 to 2012-09-30	-19,664	USD	274
2011-10-01 to 2012-09-30	-19,664	USD	366
2011-07-01 to 2011-09-30	-3,514	USD	92
2011-01-01 to 2011-09-30	12,936	USD	273
2010-10-01 to 2011-09-30	12,936	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-10-01 to 2012-09-30	-14,840	USD	366
2010-10-01 to 2011-09-30	4,955	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	0	USD	92
2011-07-01 to 2011-09-30	0	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-10-01 to 2012-09-30	14,690	USD	366
2010-10-01 to 2011-09-30	20,045	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-10-01 to 2012-09-30	0	USD	366
2010-10-01 to 2011-09-30	0	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-09-30	-279,428	USD
At 2011-12-31	-259,764	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	0	USD	274
2011-01-01 to 2011-09-30	0	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-2,273	USD	92
2012-01-01 to 2012-09-30	-15,624	USD	274
2011-07-01 to 2011-09-30	-2,430	USD	92
2011-01-01 to 2011-09-30	-8,471	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-09-30	0	USD
At 2011-12-31	150	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-4,040	USD	274
2011-01-01 to 2011-09-30	-3,593	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-09-30	31,136	USD
At 2011-12-31	26,311	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-09-30	0	USD
At 2011-12-31	6	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	15,624	USD	274
2011-01-01 to 2011-09-30	8,471	USD	273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-09-30	0	USD
At 2011-12-31	0	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	0	USD	274
2011-01-01 to 2011-09-30	0	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-09-30	11,155,008	shares
At 2011-12-31	11,155,008	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-09-30	63,885	USD
At 2011-12-31	63,885	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2012-09-30	0	USD
At 2011-12-31	0	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-09-30	0	USD
At 2011-12-31	0	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-09-30	1,090	USD
At 2011-12-31	300	USD

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-01-01 to 2012-09-30	-4,040	USD	274
2011-01-01 to 2011-09-30	-3,593	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-10-01 to 2012-09-30	-6	USD	366
2010-10-01 to 2011-09-30	-12,194	USD	365

Inspect the source

Entity: ACTINIUM PHARMACEUTICALS, INC. / CIK 0001388320
Captured: 2026-09-20T07:59:08.087Z
SEC response SHA-256: 8b2cf9a9df391f2441e59da237c67a180665686e2082a76d5298eb6715d76292

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001388320.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))